Taking Full Advantage of Service Providers

Pharmaceutical Technology Europe™ spoke to Jason King, director, BD at Ascend, on the various aspects of working with a partner for CTM, from the advantages of CTM to region-specific barriers potential partners could face. King (Ascend): Yes, and this happens quite often since many clinical manufact...

Full description

Saved in:
Bibliographic Details
Published in:Pharmaceutical technology Europe 2024-04, Vol.36 (4), p.33-34
Main Author: Husni, Daria
Format: Article
Language:English
Subjects:
Clinical trials
Gene therapy
Good Manufacturing Practice
Manufacturing
Outsourcing
Product development
Product testing
Teams
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Pharmaceutical Technology Europe™ spoke to Jason King, director, BD at Ascend, on the various aspects of working with a partner for CTM, from the advantages of CTM to region-specific barriers potential partners could face. King (Ascend): Yes, and this happens quite often since many clinical manufacturers do not have on-site capacity for all the analytical and testing services required. King (Ascend): Sourcing a cell and gene therapy CDMO can be trickier due to the maturity of the market.
ISSN:1753-7967